The stock of MAIA Biotechnology Inc (MAIA) has gone up by 6.24% for the week, with a 13.33% rise in the past month and a 39.72% rise in the past quarter. The volatility ratio for the week is 6.80%, and the volatility levels for the past 30 days are 6.59% for MAIA. The simple moving average for the past 20 days is 13.61% for MAIA’s stock, with a -0.23% simple moving average for the past 200 days.
Is It Worth Investing in MAIA Biotechnology Inc (AMEX: MAIA) Right Now?
Moreover, the 36-month beta value for MAIA is 0.05. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MAIA is 21.93M and currently, short sellers hold a 1.80% of that float. On July 09, 2025, MAIA’s average trading volume was 344.78K shares.
MAIA) stock’s latest price update
The stock of MAIA Biotechnology Inc (AMEX: MAIA) has increased by 10.86% when compared to last closing price of $1.84.Despite this, the company has seen a gain of 6.24% in its stock price over the last five trading days. businesswire.com reported 2025-07-09 that CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer.
MAIA Trading at 9.91% from the 50-Day Moving Average
After a stumble in the market that brought MAIA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.89% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MAIA starting from Smith Stan, who purchase 33,333 shares at the price of $1.50 back on Jun 03 ’25. After this action, Smith Stan now owns 1,305,059 shares of MAIA Biotechnology Inc, valued at $50,000 using the latest closing price.
Guerrero Ramiro, the Director of MAIA Biotechnology Inc, purchase 20,000 shares at $1.50 during a trade that took place back on May 08 ’25, which means that Guerrero Ramiro is holding 588,218 shares at $30,000 based on the most recent closing price.
Stock Fundamentals for MAIA
The total capital return value is set at -2.71. Equity return is now at value -1131.02, with -191.48 for asset returns.
Currently, EBITDA for the company is -16.96 million with net debt to EBITDA at 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.35.
Conclusion
To wrap up, the performance of MAIA Biotechnology Inc (MAIA) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
